Mary Birchler

Title: Mary Birchler: Innovator in Modified Proteins and Peptides

Introduction

Mary Birchler is a notable inventor based in King of Prussia, PA (US). She has made significant contributions to the field of biochemistry, particularly in the development of modified proteins and peptides. Her innovative work has led to advancements that can impact various applications in medicine and biotechnology.

Latest Patents

Mary Birchler holds a patent for her work on modified proteins and peptides. The patent focuses on molecules that have a reduced ability to bind to pre-existing antibodies. These modified protein and peptide molecules can include C-terminal additions, extensions, or tags, as well as specific amino acid substitutions. The patent also discusses the uses and formulations of compositions that incorporate these modified molecules, which can include proteins, peptides, antigen-binding molecules, antibodies, or antibody fragments such as single variable domains.

Career Highlights

Mary Birchler is associated with Glaxo Group Limited, where she has been able to apply her expertise in protein modification. Her work has contributed to the understanding and development of therapeutic agents that can be more effective in clinical settings. With her innovative approach, she has positioned herself as a key player in her field.

Collaborations

Mary has collaborated with notable colleagues, including Claire Ashman and Rudolf M T De Wildt. These collaborations have allowed her to expand her research and contribute to various projects that enhance the understanding of protein interactions and modifications.

Conclusion

Mary Birchler's contributions to the field of modified proteins and peptides demonstrate her innovative spirit and dedication to advancing biochemistry. Her patent and work at Glaxo Group Limited highlight her role as a significant inventor in the industry.